1. Market Research
  2. > Healthcare
  3. > Medical Device Market Trends
  4. > North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020

North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020

Summary

GlobalData’s new report, "North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020", provides key market data on the North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures. The report provides procedure volumes within market segments - Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures (ERCP Plastic Biliary Stenting Procedures and ERCP Metal Biliary Stenting Procedures (ERCP Metal - Non-Covered Biliary Stenting Procedures, ERCP Metal - Partially Covered Biliary Stenting Procedures and ERCP Metal - Fully Covered Biliary Stenting Procedures)) and Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures without Stenting.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.

Scope

- Procedure volumes by segment - Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures (ERCP Plastic Biliary Stenting Procedures and ERCP Metal Biliary Stenting Procedures (ERCP Metal - Non-Covered Biliary Stenting Procedures, ERCP Metal - Partially Covered Biliary Stenting Procedures and ERCP Metal - Fully Covered Biliary Stenting Procedures)) and Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures without Stenting.
- Projections for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.

Reasons to buy

- Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Develop market-entry and market expansion strategies.

Table Of Contents

North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Segmentation 5
2.3 Definitions of Procedures Covered in the Report 6
3 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, North America 7
3.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, North America, 2005-2020 7
3.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, North America, 2005-2020, Category Comparison by Procedures, 2005-2020 9
3.3 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, North America, 2005-2013 11
3.4 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, North America, 2013-2020 13
4 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Canada 15
4.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Canada, 2005-2013 15
4.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Canada, 2013-2020 17
4.2.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Canada, 2005-2013 19
4.2.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Canada, 2013-2020 21
4.2.2.1 ERCP Metal Biliary Stenting Procedures, Canada, 2005-2013 23
4.2.2.2 ERCP Metal Biliary Stenting Procedures, Canada, 2013-2020 25
5 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Mexico 27
5.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Mexico, 2005-2013 27
5.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Mexico, 2013-2020 29
5.2.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Mexico, 2005-2013 31
5.2.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Mexico, 2013-2020 33
5.2.2.1 ERCP Metal Biliary Stenting Procedures, Mexico, 2005-2013 35
5.2.2.2 ERCP Metal Biliary Stenting Procedures, Mexico, 2013-2020 37
6 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, United States 39
6.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, United States, 2005-2013 39
6.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, United States, 2013-2020 41
6.2.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, United States, 2005-2013 43
6.2.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, United States, 2013-2020 45
6.2.2.1 ERCP Metal Biliary Stenting Procedures, United States, 2005-2013 47
6.2.2.2 ERCP Metal Biliary Stenting Procedures, United States, 2013-2020 49
7 Appendix 51
7.1 Research Methodology 52
7.1.1 Coverage 52
7.1.2 Secondary Research 52
7.1.3 Primary Research 53
7.1.4 Market Modeling and Forecasting 54
7.1.5 Company Share Analysis 57
7.1.6 Distribution Share Analysis 58
7.2 Expert Panel 58
7.3 GlobalData Consulting 59
7.4 Contact Us 59
7.5 Disclaimer 59

1.1 List of Tables
Table 1: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, North America, Category Comparison by Procedures, 2005-2020 10
Table 2: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Canada, Historic, 2005-2013 16
Table 3: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Canada, Forecast, 2013-2020 18
Table 4: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Canada, Historic, 2005-2013 20
Table 5: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Canada, Forecast, 2013-2020 22
Table 6: ERCP Metal Biliary Stenting Procedures, Canada, Historic, 2005-2013 24
Table 7: ERCP Metal Biliary Stenting Procedures, Canada, Forecast, 2013-2020 26
Table 8: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Mexico, Historic, 2005-2013 28
Table 9: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Mexico, Forecast, 2013-2020 30
Table 10: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Mexico, Historic, 2005-2013 32
Table 11: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Mexico, Forecast, 2013-2020 34
Table 12: ERCP Metal Biliary Stenting Procedures, Mexico, Historic, 2005-2013 36
Table 13: ERCP Metal Biliary Stenting Procedures, Mexico, Forecast, 2013-2020 38
Table 14: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, United States, Historic, 2005-2013 40
Table 15: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, United States, Forecast, 2013-2020 42
Table 16: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, United States, Historic, 2005-2013 44
Table 17: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, United States, Forecast, 2013-2020 46
Table 18: ERCP Metal Biliary Stenting Procedures, United States, Historic, 2005-2013 48
Table 19: ERCP Metal Biliary Stenting Procedures, United States, Forecast, 2013-2020 50
Table 20: Total Number of Primary Research Participants, General Surgery Market, by Country 54

1.2 List of Figures
Figure 1: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, North America, 2005-2020 7
Figure 2: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, North America, Category Comparison by Procedures, 2005-2020 9
Figure 3: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, North America, Historic, 2005-2013 11
Figure 4: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, North America, Forecast, 2013-2020 13
Figure 5: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Canada, Historic, 2005-2013 15
Figure 6: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Canada, Forecast, 2013-2020 17
Figure 7: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Canada, Historic, 2005-2013 19
Figure 8: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Canada, Forecast, 2013-2020 21
Figure 9: ERCP Metal Biliary Stenting Procedures, Canada, Historic, 2005-2013 23
Figure 10: ERCP Metal Biliary Stenting Procedures, Canada, Forecast, 2013-2020 25
Figure 11: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Mexico, Historic, 2005-2013 27
Figure 12: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Mexico, Forecast, 2013-2020 29
Figure 13: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Mexico, Historic, 2005-2013 31
Figure 14: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Mexico, Forecast, 2013-2020 33
Figure 15: ERCP Metal Biliary Stenting Procedures, Mexico, Historic, 2005-2013 35
Figure 16: ERCP Metal Biliary Stenting Procedures, Mexico, Forecast, 2013-2020 37
Figure 17: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, United States, Historic, 2005-2013 39
Figure 18: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, United States, Forecast, 2013-2020 41
Figure 19: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, United States, Historic, 2005-2013 43
Figure 20: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, United States, Forecast, 2013-2020 45
Figure 21: ERCP Metal Biliary Stenting Procedures, United States, Historic, 2005-2013 47
Figure 22: ERCP Metal Biliary Stenting Procedures, United States, Forecast, 2013-2020 49
Figure 23: GlobalData Epidemiology-Based Forecasting Model 56
Figure 24: GlobalData Capital Equipment-Based Forecasting Model 57
Figure 25: Primary Interviews by Participant Type (%) 58

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

  • $ 33500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 33-country survey from VPGMarketResearch.com contains over 900 pages, 380 tables and provides granular data and analysis not available elsewhere. The survey is designed to help current suppliers and ...

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

  • $ 30000
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 820 pages and 418 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.